or Try an Advanced Search...

    Technical Analysis for MRNA - Moderna, Inc.

    Grade Last Price % Change Price Change
    D 42.53 0.33% 0.14
    MRNA closed up 10.1 percent on Thursday, January 23, 2025, on 1.33 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    28 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical MRNA trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.33%
    Crossed Above 50 DMA Bullish 0.33%
    MACD Bullish Signal Line Cross Bullish 0.33%
    Expansion Pivot Buy Setup Bullish Swing Setup 0.33%
    Multiple of Ten Bullish Other 0.33%
    Wide Bands Range Expansion 0.33%
    Up 3 Days in a Row Strength 0.33%
    Up 4 Days in a Row Strength 0.33%
    20 DMA Resistance Bearish 10.47%
    50 DMA Resistance Bearish 10.47%
    Older End-of-Day Signals for MRNA ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 1 hour ago
    2x Volume Pace about 1 hour ago
    1.5x Volume Pace about 1 hour ago
    3x Volume Pace about 1 hour ago
    Up 5% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    MRNA Chart by TradingView

    Profile

    Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: S&P 500 Cancer Life Sciences Nasdaq 100 Biology Vaccines Coronavirus RNA Cancer Vaccine Avian Influenza Messenger RNA

    Is MRNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 24 Moderna Yo-Yos After European Officials Ink Supply Deal For Covid Shots
    Jan 24 Why I Don’t Believe Larry Ellison’s Moderna Stock Hype
    Jan 24 Moderna extends gains as EU offers COVID vaccine contract
    Jan 24 Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
    Jan 24 Trending tickers: Bitcoin, Boeing, Burberry, TripAdvisor, and Moderna
    Jan 24 Why Moderna Inc. (MRNA) Is Skyrocketing?
    Jan 23 S&P 500 Gains and Losses Today: Electronic Arts Drops as Game Maker Cuts Forecast
    Jan 23 How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
    Jan 23 Why Moderna, Inc. (MRNA) Soared on Wednesday
    Jan 22 Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines
    See more MRNA news...

    Comments

    Indicators

    Indicator Value
    52 Week High 170.47
    52 Week Low 31.94
    Average Volume 10,099,341
    200-Day Moving Average 84.71
    50-Day Moving Average 40.75
    20-Day Moving Average 39.50
    10-Day Moving Average 37.44
    Average True Range 3.22
    RSI (14) 55.56
    ADX 16.06
    +DI 30.04
    -DI 22.32
    Chandelier Exit (Long, 3 ATRs) 39.27
    Chandelier Exit (Short, 3 ATRs) 41.59
    Upper Bollinger Bands 46.80
    Lower Bollinger Band 32.21
    Percent B (%b) 0.7
    BandWidth 36.94
    MACD Line -1.33
    MACD Signal Line -1.50
    MACD Histogram 0.1733
    Fundamentals Value
    Market Cap 16.31 Billion
    Num Shares 385 Million
    EPS -5.86
    Price-to-Earnings (P/E) Ratio -7.23
    Price-to-Sales 2.58
    Price-to-Book 1.09
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 50.70
    Resistance 3 (R3) 49.83 46.18 49.32
    Resistance 2 (R2) 46.18 44.07 46.62 48.85
    Resistance 1 (R1) 44.29 42.76 45.24 45.16 48.39
    Pivot Point 40.64 40.64 41.12 41.08 40.64
    Support 1 (S1) 38.75 38.53 39.70 39.62 36.39
    Support 2 (S2) 35.10 37.22 35.54 35.93
    Support 3 (S3) 33.21 35.10 35.47
    Support 4 (S4) 34.08